Monthly vs. biweekly alirocumab in clinical practice
Dear EditorLDL-cholesterol lowering remains a central strategy in atherosclerotic cardiovascular disease prevention and proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a...
Authors
- Francesco Sbrana (ORCID: https://orcid.org/0000-0003-4607-0373)
- Beatrice Dal Pino
Institutions
- Fondazione Toscana Gabriele Monasterio (IT)
Publication Details
- Journal
- Acta cardiologica. Supplementum
- Published
- 2026-08-03
- DOI
- https://doi.org/10.1080/00015385.2026.2712715
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00